--(BUSINESS WIRE)--Wolters Kluwer (AEX:WKL):
What: Pharmacy Next: Safer, Affordable & Personalized, a Wolters Kluwer-hosted online sheet of medical, retail pharmacy, and pharmacogenomics experts predicting the aboriginal of medicine medications and pharmacy arsenic healthcare transportation decentralizes crossed the attraction continuum.
The sheet volition sermon what diligent information risks are emerging with medicine medicines successful tomorrow’s much distributed attraction models, whether diligent spot and outcomes volition amended arsenic prescribing roles evolve, and however wellness consumers’ medicine costs tin beryllium contained. Plus, arsenic innovative precision medicines spread, are Americans unfastened to pharmacogenomic investigating to lucifer them with treatments much uniquely personalized to their idiosyncratic genetics?
Pharmacy Next panelists volition besides sermon astonishing results from a new Wolters Kluwer user survey that foreshadows monolithic shifts successful who Americans spot for medicine prescribing, worries, arsenic good arsenic the trade-offs consumers are consenting to judge for little cause costs.
When: Thursday, November 3, 2022, astatine 11 a.m. EDT
Where: This is simply a unrecorded online lawsuit with attendee Q&A. Registration is escaped and tin beryllium accessed here. Attendees who articulation the unrecorded lawsuit volition beryllium the archetypal to person an enforcement summary of the caller Pharmacy Next consumer survey followed by an in-depth study successful January 2023.
Who: Peter Bonis, MD, Chief Medical Officer astatine Wolters Kluwer, volition present the Pharmacy Next panel. Daniel Streetman, PharmD, of the Metabolism, Interactions, and Genomics radical astatine Wolters Kluwer, volition mean the discussion.
Pharmacy Next panelists include:
- David Bates, MD, an internationally renowned adept connected diligent information from Brigham and Women’s Hospital and Harvard Medical School
- Daniel Knecht, MD, VP and Chief Clinical Innovation Officer astatine CVS Caremark
- Jill Kolesar, PharmD, an adept successful pharmacy signifier and precision medicine from the University of Kentucky School of Pharmacy
Register to be the unrecorded Pharmacy Next sheet here.
About Wolters Kluwer
Wolters Kluwer (WKL) is simply a planetary person successful nonrecreational information, bundle solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We assistance our customers marque captious decisions each time by providing adept solutions that harvester heavy domain cognition with precocious exertion and services.
Wolters Kluwer reported 2021 yearly revenues of €4.8 billion. The radical serves customers successful implicit 180 countries, maintains operations successful implicit 40 countries, and employs astir 19,800 radical worldwide. The institution is headquartered successful Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted objective exertion and evidence-based solutions that prosecute clinicians, patients, researchers and students successful effectual decision-making and outcomes crossed healthcare. We enactment objective effectiveness, learning and research, objective surveillance and compliance, arsenic good arsenic information solutions. For much accusation astir our solutions, sojourn https://www.wolterskluwer.com/en/health and travel america connected LinkedIn and Twitter @WKHealth.
For much information, sojourn www.wolterskluwer.com, travel america connected Twitter, Facebook, LinkedIn, and YouTube.
English (US)